Light Irrevocable Trust #1 dated April 22, 2019 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 4:15 pm Unchanged | 2024-12-31 | 13G | Design Therapeutics, Inc. DSGN | Light Irrevocable Trust #1 dated April 22, 2019 | 3,834,355 6.900% | 0 (Unchanged) | Filing |
| 2022-02-09 4:30 pm Purchase | 2021-12-31 | 13G | Design Therapeutics, Inc. DSGN | Light Irrevocable Trust #1 dated April 22, 2019 | 3,834,355 6.900% | 3,834,355 (New Position) | Filing |